Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D known ✓ | P28221 | 1/20 | 0.42 |
| ▸ | HTR1B known ✓ | P28222 | 1/20 | 0.42 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.54 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.54 |
| ▸ | EGFR | P00533 | 5/20 | 0.51 |
| ▸ | IGF1R | P08069 | 5/20 | 0.51 |
| ▸ | FLT4 | P35916 | 5/20 | 0.51 |
| ▸ | KDR | P35968 | 5/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.49 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.49 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.49 |
| ▸ | HTR6 | P50406 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL16026931 | 0.89 | HSD17B10 (0.54) | AKR1B10AKR1B1EGFRIGF1RFLT4 | |
| Bromide SCHEMBL16026825 | 0.89 | PTGDR2 (0.51) | AKR1B10AKR1B1EGFRIGF1RFLT4 | |
| Bromide SCHEMBL16026860 | 0.87 | PTGDR2 (0.50) | ALDH1A1PTGDR2 | |
| Bromide SCHEMBL16026715 | 0.87 | PTGDR2 (0.49) | HSD17B10PTGDR2KDM4ELMNA | |
| Bromide SCHEMBL2430564 | 0.85 | KDM4E (0.58) | HSD17B10MEN1MAPTKMT2AALDH1A1 | |
| Bromide SCHEMBL16026864 | 0.85 | PTGDR2 (0.49) | EGFRIGF1RFLT4KDRHSD17B10 | |
| SCHEMBL27989288 | 0.83 | KDM4E (0.59) | HSD17B10MEN1MAPTKMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL27883098 | 0.83 | KDM4E (0.61) | HSD17B10MEN1KMT2AALDH1A1PTGDR2 | |
| SCHEMBL16026810 | 0.78 | AKR1B10 (0.48) | AKR1B10AKR1B1HSD17B10MEN1MAPT | |
| SCHEMBL16026850 | 0.78 | PTGDR2 (0.62) | AKR1B10AKR1B1HSD17B10MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2558447-B1 | 3-(HETEROARYL-AMINO)-1,2,3,4-TETRAHYDRO-9H-CARBAZOLE DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS | ACTELION PHARMACEUTICALS LTD (CH) | 2014-09-17 | — | — | EP | disclosed |